Yoshifumi Soejima - Concepedia

Author

Yoshifumi Soejima

Ureshino Medical Center

Also Known As

Y SOEJIMA, Y Soejima, Y. SOEJIMA, Y. Soejima, Yoshifumi SOEJIMA, Yoshifumi Soejima

Publications

587

Citations

H-Index

Concepts

All Affiliations

Ureshino Medical Center Nagasaki University Nagasaki Medical Center Kawasaki Medical School Nagasaki Municipal Hospital

About

Yoshifumi Soejima is an author at Ureshino Medical Center specializing in medicine, cancer therapeutics, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	199
2	Pathology	5	5	145
3	Health Sciences	4	4	118
4	Gastroenterology	1	1	11
5	Immunology	1	1	52

Yoshifumi Soejima

Publications

518

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA) Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami, Journal of Clinical Oncology	2014	261
Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy. Kenji Eguchi, Satoru Sasaki, Tomohide Tamura, PubMed ImmunologyPathologyPharmacotherapyMetronomic ChemotherapyAdvanced Malignancy	1989	52
Randomized phase III trial of erlotinib (E) versus docetaxel (D) as second- or third-line therapy in patients with advanced non-small cell lung cancer (NSCLC) who have wild-type or mutant epidermal growth factor receptor (EGFR): Docetaxel and Erlotinib Lung Cancer Trial (DELTA). Yoshio Okano, Masahiko Ando, Kazuhiro Asami, Journal of Clinical Oncology Advanced NsclcMedicineCancer ManagementPhase Iii TrialClinical Trials	2013	39
Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A16 and UGT1A127 with Severe Neutropenia Yoichi Nakamura, Hiroshi Soda, Mikio Oka, Journal of Thoracic Oncology Phase Ii TrialMedicineMetronomic TherapyPathologySevere Neutropenia	2010	33
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer Minoru Fukuda, Mikio Oka, Hiroshi Soda, Cancer Chemotherapy and Pharmacology Non-small-cell Lung CancerMedicinePharmacologyPhase Ii StudyAnti-cancer Agent	2004	27
Human Early Liver Regeneration after Hepatectomy in Patients with Hepatocellular Carcinoma: Special Reference to Age Ken Shirabe, Tadashi Motomura, Kazuki Takeishi, Scandinavian Journal of Surgery	2013	27
A Randomized Prospective Study of Imipenem-Cilastatin With or Without Amikacin as an Empirical Antibiotic Treatment for Febrile Neutropenic Patients Akira Kojima, Tetsu Shinkai, Yoshifumi Soejima, American Journal of Clinical Oncology	1994	20
Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer Minoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita, Cancer Chemotherapy and Pharmacology Radiation TherapyMedicineConcurrent Split-course RadiotherapyPhase Ii StudyCancer Treatment	2012	16
Successful treatment of theophylline toxicity by upper gastrointestinal endoscopy Sho Saeki, T Shimoda, Hitomi Sakai, Respiratory Medicine GastroenterologyGi TechniqueInterventional EndoscopyMedicineTheophylline Toxicity	2003	11
Hepatic Artery Pseudoaneurysms in a Patient Treated for Miliary Tuberculosis. Hiroko Tsurutani, Michio Tomonaga, Tetsuji Yamaguchi, Internal Medicine	2000	11

Page 1